{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T04:17:38Z","timestamp":1749010658376,"version":"3.41.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,6,20]],"date-time":"2016-06-20T00:00:00Z","timestamp":1466380800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1211313N"],"award-info":[{"award-number":["1211313N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007229","name":"Bijzonder Onderzoeksfonds","doi-asserted-by":"publisher","award":["BOF27327"],"award-info":[{"award-number":["BOF27327"]}],"id":[{"id":"10.13039\/501100007229","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovative Medicine Initiative Joint Undertaking","award":["115151"],"award-info":[{"award-number":["115151"]}]},{"name":"Innovative Medicine Initiative Joint Undertaking","award":["115151"],"award-info":[{"award-number":["115151"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11307-016-0974-5","type":"journal-article","created":{"date-parts":[[2016,6,20]],"date-time":"2016-06-20T14:02:25Z","timestamp":1466431345000},"page":"109-119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of [18F]Fluorothymidine as a Biomarker for Early Therapy Response in a Mouse Model of Colorectal Cancer"],"prefix":"10.1007","volume":"19","author":[{"given":"Sara","family":"Rapic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christel","family":"Vangestel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"Verhaeghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Thomae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Pauwels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Van den Wyngaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Staelens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1285-9117","authenticated-orcid":false,"given":"Sigrid","family":"Stroobants","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,20]]},"reference":[{"key":"974_CR1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359\u2013E386","journal-title":"Int J Cancer"},{"key":"974_CR2","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/3337","volume":"4","author":"AF Shields","year":"1998","unstructured":"Shields AF, Grierson JR, Dohmen BM et al (1998) Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 4:1334\u20131336","journal-title":"Nat Med"},{"key":"974_CR3","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.2967\/jnumed.107.046391","volume":"49","author":"JR Bading","year":"2008","unstructured":"Bading JR, Shields AF (2008) Imaging of cell proliferation: status and prospects. J Nucl Med 49:64S\u201380S","journal-title":"J Nucl Med"},{"key":"974_CR4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11373-007-9175-1","volume":"14","author":"C-M Hu","year":"2007","unstructured":"Hu C-M, Chang Z-F (2007) Mitotic control of dTTP pool: a necessity or coincidence? J Biomed Sci 14:491\u2013497","journal-title":"J Biomed Sci"},{"key":"974_CR5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0065-2571(94)00014-T","volume":"35","author":"B Munch-Petersen","year":"1995","unstructured":"Munch-Petersen B, Cloos L, Jensen HK, Tyrsted G (1995) Human thymidine kinase 1. Regulation in normal and malignant cells. Adv Enzym Regul 35:69\u201389","journal-title":"Adv Enzym Regul"},{"key":"974_CR6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbrc.2003.11.147","volume":"313","author":"C-L Li","year":"2004","unstructured":"Li C-L, Lu C-Y, Ke P-Y, Chang Z-F (2004) Perturbation of ATP-induced tetramerization of human cytosolic thymidine kinase by substitution of serine-13 with aspartic acid at the mitotic phosphorylation site. Biochem Biophys Res Commun 313:587\u2013593","journal-title":"Biochem Biophys Res Commun"},{"key":"974_CR7","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ejca.2011.11.035","volume":"48","author":"D Soloviev","year":"2012","unstructured":"Soloviev D, Lewis D, Honess D, Aboagye E (2012) [(18)F]FLT: an imaging biomarker of tumour proliferation for assessment of tumour response to treatment. Eur J Cancer 48:416\u2013424","journal-title":"Eur J Cancer"},{"key":"974_CR8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s11307-011-0529-8","volume":"14","author":"SR Mudd","year":"2011","unstructured":"Mudd SR, Holich KD, Voorbach MJ et al (2011) Pharmacodynamic evaluation of irinotecan therapy by FDG and FLT PET\/CT imaging in a colorectal cancer xenograft model. Mol Imaging Biol 14:617\u2013624","journal-title":"Mol Imaging Biol"},{"key":"974_CR9","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2967\/jnumed.112.108456","volume":"54","author":"ET McKinley","year":"2013","unstructured":"McKinley ET, Smith RA, Zhao P et al (2013) 3\u2032-Deoxy-3\u2032-18F-fluorothymidine pet predicts response to V600EBRAF-targeted therapy in preclinical models of colorectal cancer. J Nucl Med 54:424\u2013430","journal-title":"J Nucl Med"},{"key":"974_CR10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11307-011-0514-2","volume":"14","author":"G Tomasi","year":"2011","unstructured":"Tomasi G, Turkheimer F, Aboagye E (2011) Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future. Mol Imaging Biol 14:131\u2013146","journal-title":"Mol Imaging Biol"},{"key":"974_CR11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00004647-200106000-00002","volume":"21","author":"RN Gunn","year":"2001","unstructured":"Gunn RN, Gunn SR, Cunningham VJ (2001) Positron emission tomography compartmental models. J Cereb Blood Flow Metab 21:635\u2013652","journal-title":"J Cereb Blood Flow Metab"},{"key":"974_CR12","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.2967\/jnumed.108.053215","volume":"49","author":"SJ Kim","year":"2008","unstructured":"Kim SJ, Lee JS, Im KC et al (2008) Kinetic modeling of 3\u201c-deoxy-3-\u201d18F-fluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice. J Nucl Med 49:2057\u20132066","journal-title":"J Nucl Med"},{"key":"974_CR13","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa071834","volume":"357","author":"DJ Jonker","year":"2007","unstructured":"Jonker DJ, O\u2019Callaghan CJ, Karapetis CS et al (2007) Cetuximab for the treatment of colorectal cancer. N Engl J Med 357:2040\u20132048","journal-title":"N Engl J Med"},{"key":"974_CR14","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1200\/JCO.2008.18.0786","volume":"26","author":"F Nicolantonio Di","year":"2008","unstructured":"Di Nicolantonio F, Martini M, Molinari F et al (2008) Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer. J Clin Oncol 26:5705\u20135712","journal-title":"J Clin Oncol"},{"key":"974_CR15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ejca.2015.01.054","volume":"51","author":"F Pietrantonio","year":"2015","unstructured":"Pietrantonio F, Petrelli F, Coinu A et al (2015) Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: a meta-analysis. Eur J Cancer 51:587\u2013594","journal-title":"Eur J Cancer"},{"key":"974_CR16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1634\/theoncologist.6-1-66","volume":"6","author":"ML Rothenberg","year":"2001","unstructured":"Rothenberg ML (2001) Irinotecan (CPT-11): recent developments and future directions\u2014colorectal cancer and beyond. Oncologist 6:66\u201380","journal-title":"Oncologist"},{"key":"974_CR17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s002800051010","volume":"45","author":"DM Voeller","year":"2000","unstructured":"Voeller DM, Grem JL, Pommier Y et al (2000) Identification and proposed mechanism of action of thymidine kinase inhibition associated with cellular exposure to camptothecin analogs. Cancer Chemother Pharmacol 45:409\u2013416","journal-title":"Cancer Chemother Pharmacol"},{"key":"974_CR18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2967\/jnumed.108.055152","volume":"50","author":"EP Visser","year":"2009","unstructured":"Visser EP, Disselhorst JA, Brom M et al (2009) Spatial resolution and sensitivity of the Inveon small-animal PET scanner. J Nucl Med 50:139\u2013147","journal-title":"J Nucl Med"},{"key":"974_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2310\/7290.2014.00013","volume":"13","author":"S Deleye","year":"2014","unstructured":"Deleye S, Heylen M, Deiteren A et al (2014) Continuous flushing of the bladder in rodents reduces artifacts and improves quantification in molecular imaging. Mol Imaging 13:1\u201312","journal-title":"Mol Imaging"},{"key":"974_CR20","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1369\/jhc.2009.952804","volume":"57","author":"JS Brockenbrough","year":"2009","unstructured":"Brockenbrough JS, Morihara JK, Hawes SE et al (2009) Thymidine kinase 1 and thymidine phosphorylase expression in non-small-cell lung carcinoma in relation to angiogenesis and proliferation. J Histochem Cytochem 57:1087\u20131097","journal-title":"J Histochem Cytochem"},{"key":"974_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/207504","volume":"2011","author":"W-C Lee","year":"2011","unstructured":"Lee W-C, Chang C-H, Ho C-L et al (2011) Early detection of tumor response by FLT\/MicroPET imaging in a C26 murine colon carcinoma solid tumor animal model. J Biomed Biotechnol 2011:1\u20137","journal-title":"J Biomed Biotechnol"},{"key":"974_CR22","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2967\/jnumed.109.069310","volume":"51","author":"EGC Troost","year":"2010","unstructured":"Troost EGC, Bussink J, Hoffmann AL et al (2010) 18F-FLT PET\/CT for early response monitoring and dose escalation in oropharyngeal tumors. J Nucl Med 51:866\u2013874","journal-title":"J Nucl Med"},{"key":"974_CR23","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2967\/jnumed.114.140913","volume":"55","author":"V Frings","year":"2014","unstructured":"Frings V, Yaqub M, Hoyng LL et al (2014) Assessment of simplified methods to measure 18F-FLT uptake changes in EGFR-mutated non-small cell lung cancer patients undergoing EGFR tyrosine kinase inhibitor treatment. J Nucl Med 55:1417\u20131423","journal-title":"J Nucl Med"},{"key":"974_CR24","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.2967\/jnumed.111.089482","volume":"52","author":"JS Brockenbrough","year":"2011","unstructured":"Brockenbrough JS, Souquet T, Morihara JK et al (2011) Tumor 3\u201c-deoxy-3-\u201d18F-fluorothymidine (18F-FLT) uptake by PET correlates with thymidine kinase 1 expression: static and kinetic analysis of 18F-FLT PET studies in lung tumors. J Nucl Med 52:1181\u20131188","journal-title":"J Nucl Med"},{"key":"974_CR25","first-page":"3315","volume":"8","author":"H Vesselle","year":"2002","unstructured":"Vesselle H, Grierson J, Muzi M et al (2002) In vivo validation of 3\u2032-deoxy-3\u2032-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans: correlation of [(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors. Clin Cancer Res 8:3315\u20133323","journal-title":"Clin Cancer Res"},{"key":"974_CR26","doi-asserted-by":"crossref","first-page":"e58938","DOI":"10.1371\/journal.pone.0058938","volume":"8","author":"ET McKinley","year":"2013","unstructured":"McKinley ET, Ayers GD, Smith RA et al (2013) Limits of [18F]-FLT PET as a biomarker of proliferation in oncology. PLoS ONE 8:e58938","journal-title":"PLoS ONE"},{"key":"974_CR27","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/1078-0432.CCR-11-1433","volume":"18","author":"CC Zhang","year":"2012","unstructured":"Zhang CC, Yan Z, Li W et al (2012) [18F]FLT-PET imaging does not always \u201clight up\u201d proliferating tumor cells. Clin Cancer Res 18:1303\u20131312","journal-title":"Clin Cancer Res"},{"key":"974_CR28","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11307-011-0504-4","volume":"14","author":"H Keen","year":"2011","unstructured":"Keen H, Pichler B, Kukuk D et al (2011) An evaluation of 2-deoxy-2-[18F]fluoro-D-glucose and 3\u2032-deoxy-3\u2032-[18F]-fluorothymidine uptake in human tumor xenograft models. Mol Imaging Biol 14:355\u2013365","journal-title":"Mol Imaging Biol"},{"key":"974_CR29","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.bcp.2010.08.004","volume":"80","author":"SJ Lee","year":"2010","unstructured":"Lee SJ, Kim SY, Chung JH et al (2010) Induction of thymidine kinase 1 after 5-fluorouracil as a mechanism for 3\u201c-deoxy-3-\u201d[18F]fluorothymidine flare. Biochem Pharmacol 80:1528\u20131536","journal-title":"Biochem Pharmacol"},{"key":"974_CR30","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1158\/1078-0432.CCR-09-1213","volume":"15","author":"LM Kenny","year":"2009","unstructured":"Kenny LM, Contractor KB, Stebbing J et al (2009) Altered tissue 3\u201c-deoxy-3-\u201d[18F]fluorothymidine pharmacokinetics in human breast cancer following capecitabine treatment detected by positron emission tomography. Clin Cancer Res 15:6649\u20136657","journal-title":"Clin Cancer Res"},{"key":"974_CR31","first-page":"3791","volume":"63","author":"H Barthel","year":"2003","unstructured":"Barthel H, Cleij MC, Collingridge DR et al (2003) 3\u201c-Deoxy-3-\u201d[18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Res 63:3791\u20133798","journal-title":"Cancer Res"},{"key":"974_CR32","doi-asserted-by":"crossref","first-page":"12095","DOI":"10.1074\/jbc.273.20.12095","volume":"273","author":"ZF Chang","year":"1998","unstructured":"Chang ZF, Huang DY, Chi LM (1998) Serine 13 is the site of mitotic phosphorylation of human thymidine kinase. J Biol Chem 273:12095\u201312100","journal-title":"J Biol Chem"},{"key":"974_CR33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jmb.2007.02.104","volume":"369","author":"D Segura-Pe\u00f1a","year":"2007","unstructured":"Segura-Pe\u00f1a D, Lutz S, Monnerjahn C et al (2007) Binding of ATP to TK1-like enzymes is associated with a conformational change in the quaternary structure. J Mol Biol 369:129\u2013141","journal-title":"J Mol Biol"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-016-0974-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11307-016-0974-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-016-0974-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-016-0974-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T22:16:17Z","timestamp":1748988977000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11307-016-0974-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,20]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["974"],"URL":"https:\/\/doi.org\/10.1007\/s11307-016-0974-5","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"type":"print","value":"1536-1632"},{"type":"electronic","value":"1860-2002"}],"subject":[],"published":{"date-parts":[[2016,6,20]]}}}